Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
36.65
+0.39 (1.08%)
Nov 24, 2025, 2:09 PM EST - Market open
Maze Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$37.00
Upside
+0.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | -1.77% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $27 → $37 | Buy | Maintains | $27 → $37 | +0.95% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +36.43% | Sep 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $19 → $34 | Strong Buy | Maintains | $19 → $34 | -7.23% | Sep 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $50 | Strong Buy | Maintains | $34 → $50 | +36.43% | Sep 12, 2025 |
| BTIG | BTIG | Strong Buy Maintains $30 → $37 | Strong Buy | Maintains | $30 → $37 | +0.95% | Sep 12, 2025 |
| BTIG | BTIG | Strong Buy Maintains $30 → $37 | Strong Buy | Maintains | $30 → $37 | +0.95% | Sep 11, 2025 |
| BTIG | BTIG | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | -18.14% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | -7.23% | Jul 23, 2025 |
| Wedbush | Wedbush | Buy Initiates $17 | Buy | Initiates | $17 | -53.62% | Jul 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | -48.16% | Apr 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | -48.16% | Feb 25, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $28 | Buy | Initiates | $28 | -23.60% | Feb 25, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $30 | Buy | Initiates | $30 | -18.14% | Feb 25, 2025 |